Ecoplast FY26 Annual Report filed; 44th AGM on Sep 7

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.7%Reaction day

₹485.00

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-3.1% vs market

Plastic Products - Industrial peers, median of 38sector+0.0%-2.7% vs sector

On the reaction day the stock moved 3.1 pts less than Nifty Microcap 250 and 2.7 pts less than its Plastic Products - Industrial peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.7+0.4-3.1+0.0-2.7

Next day

-5.1+0.5-5.7+0.3-5.4

-7.6+0.6-8.2+1.4-9.0

-8.0+0.7-8.7-0.0-7.9

-9.8+1.1-10.9-0.6-9.1

-8.7+0.5-9.2+0.6-9.3

-9.1+1.3-10.4+0.0-9.1

15d

-13.4+0.5-13.9-2.0-11.4

+0.1-0.8+0.9-2.9+3.0

-1.4-0.9-0.5-4.8+3.3

—————

UpDownMarket · Nifty Microcap 250Sector · Plastic Products - Industrial peers, median of 38Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ecoplast Limited submitted its 44th Annual Report for FY 2025-26 to BSE. The 44th AGM is scheduled for September 7, 2026 in Valsad, Gujarat. Agenda includes adoption of audited financial statements, re-appointment of a director, revision in remuneration of Managing Director and three Whole-time Directors citing expanded scale after the NCLT-approved merger with Kunal Plastics Private Limited (May 14, 2026), and ratification of Cost Auditor remuneration of Rs 2.5 lakh plus taxes.

Likely market impact

Routine filing. Shareholders to vote on FY26 accounts, director re-appointment, revised pay for four directors after merger, and Cost Auditor ratification.